A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones
Leukemia · 2025
DOI: 10.1038/s41375-024-02464-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, 2025. Verfasst von Raúl Sánchez-Lanzas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Hemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: Receptor, Notch3, DNA (Cytosine-5-)-Methyltransferases, CADASIL, Hematopoietic Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Society of Hematology (ASH), Kay Kendall Leukaemia Fund (KKLF), RCUK | Medical Research Council (MRC).
Abstract (Originalsprache)
Clonal hematopoiesis (CH) is nearly universal in the elderly. The molecular and cellular mechanisms driving CH and the clinical consequences of carrying clonally derived mutant mature blood cells are poorly understood. We recently identified a C223Y mutation in the extracellular domain (ECD) of NOTCH3 as a putative CH driver in mice. Provocatively, germline NOTCH3 ECD mutations perturbing cysteine numbers cause Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a type of vascular dementia, suggesting an unexpected link between CADASIL and CH. Here, we formally demonstrated that mouse hematopoietic stem and progenitor cells (HSPCs) expressing CADASIL-related NOTCH3 C455R exhibit a proliferative advantage resulting in robust cellular expansion in vivo and in vitro. Co-expression of NOTCH3 C455R and Dnmt3a R878H , homologous to a frequent human CH mutation, increased the fitness of NOTCH3 C455R HSPCs, demonstrating their functional cooperation. Surprisingly, the presence of NOTCH3 C455R hematopoietic cells supported the expansion of Dnmt3a R878H HSPCs in a non-cell autonomous fashion in vivo, strongly suggesting that CADASIL patients and asymptomatic carriers can be highly predisposed to DNMT3A R882H -driven CH. Considering that CADASIL-related NOTCH3 mutations are more frequent in the general population than anticipated (~1 carrier in 400 people), the effect of these NOTCH3 mutations on CH development should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Hemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
- Royal Veterinary College, Hertfordshire, UK.
- Francis Crick Institute, London, UK.
- Centre for Hemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. m.ganuza@qmul.ac.uk.
ORCID-Profile: Foteini Kalampalika, Amanda Jiménez-Pompa, Paolo Gallipoli, Miguel Ganuza
Förderung
- American Society of Hematology (ASH)
- Kay Kendall Leukaemia Fund (KKLF)
- RCUK | Medical Research Council (MRC)
Zitieren
APA
Sánchez-Lanzas, R., Barclay, J., Hardas, A., Kalampalika, F., Jiménez-Pompa, A., Gallipoli, P., & Ganuza, M. (2025). A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones. Leukemia. https://doi.org/10.1038/s41375-024-02464-8
Vancouver
Sánchez-Lanzas R, Barclay J, Hardas A, Kalampalika F, Jiménez-Pompa A, Gallipoli P, et al. A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones. Leukemia. 2025. doi:10.1038/s41375-024-02464-8
BibTeX
@article{SnchezLanzas2025,
author = {Sánchez-Lanzas, Raúl and Barclay, Justin and Hardas, Alexandros and Kalampalika, Foteini and Jiménez-Pompa, Amanda and Gallipoli, Paolo and Ganuza, Miguel},
title = {A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones},
journal = {Leukemia},
year = {2025},
doi = {10.1038/s41375-024-02464-8}
}
EUVIMED